Ua neʻe iki nā hormones mai nā puke aʻo physiology pohihihi i ke kamaʻilio nui e like me ka glucagon-like peptide-1 (GLP-1). Ma muli o ke kaulana o nā agonists receptor GLP-1 lāʻau lapaʻau, ua hoʻonui koke ʻia ka hoihoi o nā mea kūʻai aku i ka "kākoʻo GLP-1" i ka wahi meaʻai, mea inu, a me nā mea hoʻohui.
He aha ka GLP-1?
ʻO GLP-1 kahi hormone peptide i hoʻokuʻu ʻia e nā cell L i loko o ka ʻōpū i ka pane ʻana i ka lawe ʻana i nā meaʻai, ʻoi aku ka ma hope o nā ʻai i loaʻa ka protein, ka momona, a me ka fiber. No loko ia o kahi papa o nā hormones i ʻike ʻia he incretins, kahi e hoʻonohonoho ai i ka digestion me ka metabolic signaling. Ke hoʻokuʻu ʻia, hana ʻo GLP-1 ma nā receptors i hoʻolaha ʻia ma waena o ka pancreas, ka ate, ka lolo, ka ʻōpū, a me ka ʻiʻo adipose, e hāʻawi ana iā ia i ka mana ma luna o kekahi mau ʻōnaehana i hoʻopili ʻia ma mua o hoʻokahi ala (Lotosky et al., 2025).
I loko o ka pancreas, hoʻonui ʻo GLP-1 i ka hoʻokuʻu ʻana o ka insulin a kākoʻo i ka hana beta-cell. I loko o ka lolo, launa pū ia me nā kikowaena makemake e hoʻolaha i ka māʻona a hōʻemi i ke ʻano ʻimi meaʻai. I loko o ka ʻōpū, hoʻolohi ia i ka hoʻokahe ʻana o ka ʻōpū, kahi e hoʻonui ai i ka manaʻo o ka piha ma hope o ka ʻai ʻana. ʻO kāna mau hana i loko o ke akepaʻa a me nā ʻiʻo iwi, me ke kākoʻo no ka synthesis glycogen a me ka hoʻolilo ʻana i ka ikehu, ke ʻano nei akā ua manaʻo ʻia he pili i kona hopena metabolic ākea (Lotosky et al., 2025).
E heluhelu pū: Nā pono o ka Milk Thistle no ke akepaʻa a me ke kō koko
Ma muli o ka wāwahi koke ʻia ʻana o GLP-1 i loko o ke kino e ka enzyme dipeptidyl peptidase-4 (DPP-4), pōkole kona puka makani hōʻailona kūlohelohe. ʻO kēia kekahi o nā kumu i hoʻomohala ʻia ai nā agonists receptor GLP-1 lāʻau lapaʻau me nā ʻano i hoʻololi ʻia e kūʻē i ka hoʻohaʻahaʻa ʻana o DPP-4 (Lotosky et al., 2025).
ʻO ia ke kumu i hoihoi ai nā kānaka noiʻi meaʻai i nā mea hoʻohui e kākoʻo i ka hana GLP-1 ponoʻī o ke kino, ma o ka hoʻoikaika ʻana i kona hoʻokuʻu ʻia ʻana a i ʻole ma ke kāohi ʻana i ka enzyme e wāwahi iā ia.
Ke kuleana o GLP-1 i ka hoʻoponopono ʻana i ka makemake
ʻAʻole i hoʻomalu ʻia ka makemake e kahi hōʻailona hoʻokahi akā e kahi pūnaewele o ke kamaʻilio ʻana o ka ʻōpū a me ka lolo, kahi e hoʻokani ai ʻo GLP-1 i kahi kuleana hoʻonohonoho. Ma hope o ka ʻai ʻana, hāʻawi nā pae GLP-1 kiʻekiʻe i ka emi ʻana o ka pōloli, ka lohi o ka hoʻokahe ʻana o ka ʻōpū, a me ka hoʻonui ʻana i nā manaʻo o ka piha. Kōkua kēia hui pū ʻana e wehewehe i ke kumu i lilo ai ʻo GLP-1 i mea nui i ka noiʻi hoʻokele kaumaha, ʻo ia hoʻi nā lāʻau lapaʻau a me nā meaʻai. ʻO ka mea nui, ʻaʻole hana ka GLP-1 ma kahi kaʻawale; launa pū ia me nā hormones ʻōpū ʻē aʻe, me ghrelin a me peptide YY, ma ke ʻano he ʻāpana o kahi ʻōnaehana hoʻoponopono makemake ākea.
ʻO GLP-1 a me ka Hana Metabolic
Ma waho aʻe o ka makemake, ua pili ka hōʻailona e pili ana iā GLP-1 i ka hoʻoponopono glucose, ka metabolism lipid, a me ka hoʻolilo ʻana i ka ikehu. I loko o nā ʻiʻo ate, kākoʻo ʻo GLP-1 i ka synthesis glycogen ma o nā ala hilinaʻi insulin a me nā ala kūʻokoʻa insulin. I loko o nā ʻiʻo adipose, ua hōʻike ʻia ʻo GLP-1 e hoʻoulu i ka thermogenesis ʻiʻo adipose brown a me ka hoʻolilo ʻana i ka ikehu, kahi ʻano hana i manaʻo ʻia he pili i ka pohō kaumaha e pili ana me nā lāʻau lapaʻau agonist receptor GLP-1 (Lotosky et al., 2025).
Ke noho nei kēia mau ʻano hana i wahi noiʻi ikaika ʻia, a ua ʻike ʻia nā hakahaka ʻike koʻikoʻi i nā palapala, ʻoiai e pili ana i ka nui o nā hopena pololei o GLP-1 i nā ʻiʻo kikoʻī.
E heluhelu pū: Nā mea hoʻohui Liposomal: He au hou o ka hoʻopili ʻana i nā meaʻai
Nā ʻAno Botanical e Kākoʻo ai i nā Ala GLP-1
Ua noiʻi nui ʻia e kahi kino noiʻi meaʻai inā hiki i nā mea i loaʻa mai nā mea kanu kikoʻī ke hoʻohuli i ka hana endogenous GLP-1, ma o ka hoʻoulu ʻana i kona hoʻokuʻu ʻia ʻana i loko o ka ʻōpū a i ʻole ma ka hoʻoponopono ʻana i ka hana DPP-4, ka enzyme kuleana no ka haki wikiwiki ʻana o GLP-1. Ua wikiwiki ka hoihoi i kēia wahi me ke kamaʻilio ākea o GLP-1, me ka nānā nui ʻana o nā mea hana i nā ʻano hana e pili ana i ka meaʻai e hana ana ma ke ala like o ka incretin e like me nā lāʻau lapaʻau GLP-1, me ka ʻole o nā huahana lāʻau lapaʻau ponoʻī.
ʻO kahi laʻana mai ka waihona ponoʻī o NaturMed Scientific ʻo Theolim, kahi hui maʻamau, i hoʻopaʻa ʻia o ka ʻili Key lime (Citrus aurantifolia) a me nā hua cocoa (Theobroma cacao) . Ma waena o kahi papahana hoʻonohonoho o ka noiʻi preclinical a me ka lapaʻau, ua loiloi ʻia ʻo Theolim no kona hopena i ka hoʻolilo ʻana i ka ikehu, ke ʻano o ke kino, a me nā māka metabolic pili. I loko o nā hiʻohiʻona cell a me nā holoholona, ua ʻike ʻia ka hui pū ʻana e kākoʻo i ka hōʻike ʻana o nā protein e pili ana i ka hana thermogenic, me ka wehe ʻana i ka protein-1 a me ka beta-3 adrenergic receptor, i kahi kekelē ʻoi aku ma mua o kēlā me kēia kumu extract wale nō (Kundimi et al., 2024).
Ua holomua ka noiʻi kanaka mai kahi hoʻokolohua crossover acute, kahi i ʻoi aku ai ke kiʻekiʻe o ka metabolic rate hoʻomaha a me ka fat oxidation ma hope o kahi mahele hoʻokahi i hoʻohālikelike ʻia me ka placebo (Ammatalli et al., 2024), a hiki i kahi hoʻokolohua randomized, double-blind, placebo-controlled 16-pule ma 120 mau pākeke momona.
E heluhelu pū hoʻi: Nā Mea Hoʻohui i hōʻailona ʻia
Ma kēlā hoʻokolohua 16-pule, ua pili ka hoʻopihapiha ʻana o Theolim me ka emi nui ʻana o ke kaumaha o ke kino a me ka momona i hoʻohālikelike ʻia me ka placebo, me ka piʻi ʻana o 33% i ka serum GLP-1 mai ka baseline ma ka pule 16, ka emi nui ʻana o ka ghrelin, a me nā hoʻomaikaʻi ʻana i nā lipid i koho ʻia a me nā māka insulin-sensitivity (Chadalavada et al., 2025). ʻO kēia kekahi o nā ʻāpana nui o nā hōʻike kanaka a hiki i kēia lā e hoʻopili ana i ka hui pū ʻana o ka meaʻai me ka hana endogenous GLP-1, ʻoiai ʻo ka hana hou ʻana kūʻokoʻa a me ke ʻano hou ʻana o nā loli biomarker e hoʻoikaika i ke kumu hōʻike.
Pōʻaiapili a me nā Palena
ʻOiai ke ulu wikiwiki nei kēia ʻāpana noiʻi, he nui nā mea e pono ai ke hoʻomaopopo ʻia. Hoʻomaka ka hapa nui o nā hōʻike mechanistic e hoʻopili ana i nā mea kanu botanical i ka hana GLP-1 i nā hiʻohiʻona cell a me nā holoholona, ʻaʻole hiki ke hoʻopili pololei ʻia i nā hopena kanaka a ʻoi aku ka maikaʻi o ka hoʻomaopopo ʻana ma ke ʻano he mua. ʻAʻole hoʻi e hoʻonui ka noiʻi Botanical GLP-1 i ka laulā o nā koi hana-hana i ʻae ʻia no nā mea hoʻohui meaʻai ma ka hapa nui o nā mana hoʻoponopono; akā naʻe, hiki iā ia ke hoʻoikaika i ke kumu ʻepekema ma lalo no nā koi e pili ana i ka māʻona, ka hoʻoponopono ʻana i ka makemake, a me ke olakino metabolic. Paipai ʻia nā mea hana a me nā lama e hoʻonoho i ka noiʻi botanical e pili ana iā GLP-1 ma ke ʻano he ʻāpana o kahi moʻolelo olakino metabolic ākea, ma mua o ke ʻano he pani meaʻai pololei no nā lāʻau lapaʻau GLP-1 i kuhikuhi ʻia.
Hoʻomaopopo: ʻO nā mea hoʻohui a me nā haʻawina i kūkākūkā ʻia ma kēia ʻatikala he mau mea hoʻohui meaʻai, ʻaʻole nā huahana lāʻau lapaʻau i laikini ʻia, a ʻaʻole i manaʻo ʻia e ʻike, mālama, ho'ōla, a pale aku paha i kekahi maʻi. ʻO nā mea kūʻai aku me nā kūlana olakino mua a i ʻole ka poʻe e lawe ana i ka lāʻau lapaʻau, me nā lāʻau lapaʻau agonist receptor GLP-1, ua ʻōlelo ʻia e kūkākūkā me kahi loea mālama ola kino kūpono ma mua o ka hoʻohana ʻana.
E hoʻomaopopo '
ʻAmmatalli, NKR, Kuricheti, SSSK, Veeramachaneni, S., Koo, YK, Ramanathan, G. lāua ʻo Yalamanchi, A. (2024) 'ʻO ka hui pū ʻana o ka Citrus aurantifolia fruit rind a me ka Theobroma cacao seed extracts supplementation e hoʻonui i nā helu metabolic i nā kumuhana momona: he randomized, placebo-controlled, cross-over study', Food & Nutrition Research, 68, ʻatikala 10745. Loaʻa ma: https://doi.org/10.29219/fnr.v68.10745
ʻO Chadalavada, A., Koo, YK, Kim, S., Veeramachaneni, S., Ramanathan, G. lāua ʻo Yalamanchi, A. (2025) 'ʻO kahi haku mele botanical thermogenic e loaʻa ana ka Citrus aurantifolia fruit rind a me nā hua Theobroma cacao e hoʻomaikaʻi i ke ʻano o ke kino i nā pākeke momona: he noiʻi lapaʻau', Food & Nutrition Research, 69, ʻatikala 12159. Loaʻa ma: https://doi.org/10.29219/fnr.v69.12159
ʻO Kundimi, S., Chinta, G., Alluri, KV, Golakoti, T., Veeramachaneni, S., Ramanathan, G. a me Sengupta, K. (2024) 'ʻO kahi ʻano hana botanical synergistic e hoʻonui i ka hoʻolilo ʻana i ka ikehu hoʻomaha a hōʻemi i ka momona i nā ʻiole i hānai ʻia i ka meaʻai momona kiʻekiʻe', Journal of the American Nutrition Association, 43(3), pp. 286–295. Loaʻa ma: https://doi.org/10.1080/27697061.2023.2280777
ʻO Lotosky, J., Jean, X., Altankhuyag, A., Khan, S., Bernotas, A., Sharafshah, A., Blum, K., Posner, A. lāua ʻo Thanos, PK (2025) 'ʻO GLP-1 a me kona kuleana i ka hana ʻana o ka glycogen: he loiloi moʻolelo', Biomedicines, 13(7), ʻatikala 1610. Loaʻa ma: https://doi.org/10.3390/biomedicines13071610
ʻŌlelo Hoʻokuʻu: ʻAʻole i loiloi ʻia ka ʻŌlelo e ka EFSA, KFDA a i ʻole FDA. ʻAʻole i manaʻo ʻia kēia huahana e ʻike, mālama, ho'ōla, a pale paha i kekahi maʻi. ʻOiai ua hoʻokumu ʻia ka ʻike i hāʻawi ʻia ma nā kuhikuhi hilinaʻi, ʻaʻole mākou e hana i kekahi mau koi a i ʻole nā hōʻoia kikoʻī. He mea nui e kūkākūkā me kāu kākā'ōlelo mālama ola no ka ʻōlelo aʻoaʻo pilikino a me ke alakaʻi e pili ana i kou olakino.
